EDGAR Filing Documents for 0001012168-99-000007

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001012168-99-000007

Filing Date

1999-01-26

Accepted

1999-01-26 00:00:00

Documents

Group Members

ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLC /ADVFARALL

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13D		SC 13D	110690
	Complete submission text file	0001012168-99-000007.txt		113345

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111

Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132

FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address

Business Address CONYERS DILL & PEARMAN CLARENDON HOUSE 2 CHURCH ST HAMILTON HM 11 BERMU D0 4412951422

AXOGEN LTD (Subject) CIK: 0001026113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-49831 | Film No.: 99513284
SIC: 2834 Pharmaceutical Preparations